![Vaccines | Free Full-Text | Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya Vaccines | Free Full-Text | Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya](https://www.mdpi.com/vaccines/vaccines-08-00260/article_deploy/html/images/vaccines-08-00260-g001.png)
Vaccines | Free Full-Text | Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
![Frontiers | FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation Frontiers | FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation](https://www.frontiersin.org/files/Articles/962912/fimmu-13-962912-HTML/image_m/fimmu-13-962912-g001.jpg)
Frontiers | FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
Evaluation of immunoregulatory cells in Duchenne muscular dystrophy and spinal muscular atrophy among African and Indian patient
![Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity | Nature Communications Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34171-2/MediaObjects/41467_2022_34171_Fig1_HTML.png)